Cargando…
The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
BACKGROUND/AIM: During cancer progression metabolic reprogramming is observed in parallel to the alternation in transcriptional profiles of malignant cells. Recent studies suggest that metabolic isoenzymes of phosphofructokinase II (PFK-II) – PFKFB3 and PFKFB4, often induced in hypoxic environment,...
Autores principales: | Trojan, Sonia E., Markiewicz, Michał J., Leśkiewicz, Katarzyna, Kocemba-Pilarczyk, Kinga A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854802/ https://www.ncbi.nlm.nih.gov/pubmed/31754349 http://dx.doi.org/10.1186/s12935-019-1005-9 |
Ejemplares similares
-
PFK15, a PFKFB3 antagonist, inhibits autophagy and proliferation in rhabdomyosarcoma cells
por: Wang, Chunhui, et al.
Publicado: (2018) -
Glucose and Palmitate Differentially Regulate PFKFB3/iPFK2 and Inflammatory Responses in Mouse Intestinal Epithelial Cells
por: Botchlett, Rachel, et al.
Publicado: (2016) -
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
por: Mondal, Susmita, et al.
Publicado: (2018) -
Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017) -
Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)